My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 188

    1.

    Stability of insulin lispro in insulin infusion systems.

    Lougheed WD, Zinman B, Strack TR, Janis LJ, Weymouth AB, Bernstein EA, Korbas AM, Frank BH.

    Diabetes Care. 1997 Jul;20(7):1061-5.PMID: 9203437 [PubMed - indexed for MEDLINE]Related articles

    2.

    In vitro stability of insulin lispro in continuous subcutaneous insulin infusion.

    DeFelippis MR, Bell MA, Heyob JA, Storms SM.

    Diabetes Technol Ther. 2006 Jun;8(3):358-68.PMID: 16800757 [PubMed - indexed for MEDLINE]Related articles

    3.

    In vitro stability of insulin aspart in simulated continuous subcutaneous insulin infusion using a MiniMed 508 insulin pump.

    Senstius J, Harboe E, Westermann H.

    Diabetes Technol Ther. 2007 Feb;9(1):75-9.PMID: 17316101 [PubMed - indexed for MEDLINE]Related articles

    4.

    Stability of U-10 and U-50 dilutions of insulin lispro.

    Stickelmeyer MP, Graf CJ, Frank BH, Ballard RL, Storms SM.

    Diabetes Technol Ther. 2000 Spring;2(1):61-6.PMID: 11467323 [PubMed - indexed for MEDLINE]Related articles

    5.

    Comparison of in vitro stability for insulin aspart and insulin glulisine during simulated use in insulin pumps.

    Senstius J, Poulsen C, Hvass A.

    Diabetes Technol Ther. 2007 Dec;9(6):517-21.PMID: 18034606 [PubMed - indexed for MEDLINE]Related articles

    6.

    Lispro insulin: adsorption and stability in selected intravenous devices.

    Ling J, Hu M, Hagerup T, Campbell RK.

    Diabetes Educ. 1999 Mar-Apr;25(2):237-45.PMID: 10531849 [PubMed - indexed for MEDLINE]Related articles

    7.

    Use of insulin lispro in continuous subcutaneous insulin infusion treatment. Results of a multicenter trial. German Humalog-CSII Study Group.

    Renner R, Pfützner A, Trautmann M, Harzer O, Sauter K, Landgraf R.

    Diabetes Care. 1999 May;22(5):784-8.PMID: 10332682 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Stability and sterility of biosynthetic human insulin stored in plastic insulin syringes for 28 days.

    Tarr BD, Campbell RK, Workman TM.

    Am J Hosp Pharm. 1991 Dec;48(12):2631-4.PMID: 1814206 [PubMed - indexed for MEDLINE]Related articles

    9.

    Comparison of human regular and lispro insulins after interruption of continuous subcutaneous insulin infusion and in the treatment of acutely decompensated IDDM.

    Attia N, Jones TW, Holcombe J, Tamborlane WV.

    Diabetes Care. 1998 May;21(5):817-21.PMID: 9589247 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabetes.

    Hanaire-Broutin H, Melki V, Bessières-Lacombe S, Tauber JP.

    Diabetes Care. 2000 Sep;23(9):1232-5.PMID: 10977011 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Cessation of insulin infusion at night-time during CSII-therapy: comparison of regular human insulin and insulin lispro.

    Reichel A, Rietzsch H, Köhler HJ, Pfützner A, Gudat U, Schulze J.

    Exp Clin Endocrinol Diabetes. 1998;106(3):168-72.PMID: 9710355 [PubMed - indexed for MEDLINE]Related articles

    12.

    Counterregulatory hormone responses after long-term continuous subcutaneous insulin infusion with lispro insulin.

    Tsui EY, Chiasson JL, Tildesley H, Barnie A, Simkins S, Strack T, Zinman B.

    Diabetes Care. 1998 Jan;21(1):93-6.PMID: 9538976 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Effect of continuous subcutaneous insulin infusion with lispro on hepatic responsiveness to glucagon in type 1 diabetes.

    Launay B, Zinman B, Tildesley HD, Strack T, Chiasson JL.

    Diabetes Care. 1998 Oct;21(10):1627-31.PMID: 9773721 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Optimal insulin pump dosing and postprandial glycemia following a pizza meal using the continuous glucose monitoring system.

    Jones SM, Quarry JL, Caldwell-McMillan M, Mauger DT, Gabbay RA.

    Diabetes Technol Ther. 2005 Apr;7(2):233-40.PMID: 15857224 [PubMed - indexed for MEDLINE]Related articles

    15.

    Effects of multiple daily injection therapy with Humalog mixtures versus separately injected insulin lispro and NPH insulin in adults with type I diabetes mellitus.

    Roach P, Bai S, Charbonnel B, Consoli A, Taboga C, Tiengo A, Bolli G; High Mix Study Group.

    Clin Ther. 2004 Apr;26(4):502-10.PMID: 15189747 [PubMed - indexed for MEDLINE]Related articles

    16.

    Improvement of HbA1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps.

    Melki V, Renard E, Lassmann-Vague V, Boivin S, Guerci B, Hanaire-Broutin H, Bringer J, Belicar P, Jeandidier N, Meyer L, Blin P, Augendre-Ferrante B, Tauber JP.

    Diabetes Care. 1998 Jun;21(6):977-82.PMID: 9614617 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Switch to multiple daily injections with insulin glargine and insulin lispro from continuous subcutaneous insulin infusion with insulin lispro: a randomized, open-label study using a continuous glucose monitoring system.

    Bode BW, Steed RD, Schleusener DS, Strange P.

    Endocr Pract. 2005 May-Jun;11(3):157-64.PMID: 16239201 [PubMed - indexed for MEDLINE]Related articles

    18.

    Time-action profiles of novel premixed preparations of insulin lispro and NPL insulin.

    Heise T, Weyer C, Serwas A, Heinrichs S, Osinga J, Roach P, Woodworth J, Gudat U, Heinemann L.

    Diabetes Care. 1998 May;21(5):800-3.PMID: 9589244 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    A comparison of insulin lispro and buffered regular human insulin administered via continuous subcutaneous insulin infusion pump.

    Raskin P, Holcombe JH, Tamborlane WV, Malone JI, Strowig S, Ahern JA, Lavent F.

    J Diabetes Complications. 2001 Nov-Dec;15(6):295-300.PMID: 11711322 [PubMed - indexed for MEDLINE]Related articles

    20.

    The action profile of lispro is not blunted by mixing in the syringe with NPH insulin.

    Joseph SE, Korzon-Burakowska A, Woodworth JR, Evans M, Hopkins D, Janes JM, Amiel SA.

    Diabetes Care. 1998 Dec;21(12):2098-102.PMID: 9839100 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity